APOTHEEK DE BUS: what changed
APOTHEEK DE BUS
Largest movements
- Current investments -€50,000
down €50,000 (-85.2%), from €58,657 to €8,657
- Cash +€43,430
up €43,430 (+19.5%), from €222,905 to €266,334
mainly Current investments (+€50,000) and Net result for the year (+€39,148)
- Receivables within one year +€16,806
up €16,806 (+13.6%), from €123,202 to €140,008
of which Other amounts receivable: +€12,806
- Reserves +€24,148
up €24,148 (+5.2%), from €465,688 to €489,836
of which Distributable reserves: +€24,148
- Other debts -€14,909
down €14,909 (-16.7%), from €89,400 to €74,491
- Gross operating margin -€32,721
down €32,721 (-16.8%), from €194,265 to €161,544
- Taxes -€11,121
down €11,121 (-69.7%), from €15,960 to €4,838
- Staff costs +€10,071
up €10,071 (+18.6%), from €54,171 to €64,242
- Write-downs +€4,369
up €4,369 (+228%), from €1,918 to €6,287
- Financial income -€1,981
down €1,981 (-46.8%), from €4,236 to €2,255
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,018,649 | €1,037,451 | +€18,802 | +1.8% |
| Fixed assets | 21/28 | €386,885 | €391,793 | +€4,908 | +1.3% |
| Tangible fixed assets | 22/27 | €386,885 | €391,793 | +€4,908 | +1.3% |
| Land and buildings | 22 | €379,680 | €381,606 | +€1,926 | +0.5% |
| Plant, machinery and equipment | 23 | €7,205 | €10,187 | +€2,982 | +41.4% |
| Current assets | 29/58 | €631,765 | €645,658 | +€13,894 | +2.2% |
| Stocks and contracts in progress | 3 | €224,913 | €230,093 | +€5,181 | +2.3% |
| Stocks | 30/36 | €224,913 | €230,093 | +€5,181 | +2.3% |
| Amounts receivable within one year | 40/41 | €123,202 | €140,008 | +€16,806 | +13.6% |
| Trade receivables | 40 | €103,010 | €107,009 | +€3,999 | +3.9% |
| Other amounts receivable | 41 | €20,192 | €32,999 | +€12,806 | +63.4% |
| Current investments | 50/53 | €58,657 | €8,657 | -€50,000 | -85.2% |
| Cash at bank and in hand | 54/58 | €222,905 | €266,334 | +€43,430 | +19.5% |
| Deferred charges and accrued income | 490/1 | €2,089 | €567 | -€1,522 | -72.9% |
| Total equity and liabilities | 10/49 | €1,018,649 | €1,037,451 | +€18,802 | +1.8% |
| Equity | 10/15 | €527,688 | €551,836 | +€24,148 | +4.6% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €465,688 | €489,836 | +€24,148 | +5.2% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Distributable reserves | 133 | €459,488 | €483,636 | +€24,148 | +5.3% |
| Amounts payable | 17/49 | €490,961 | €485,615 | -€5,346 | -1.1% |
| Amounts payable after more than one year | 17 | €286,872 | €281,816 | -€5,057 | -1.8% |
| Financial debts | 170/4 | €286,872 | €281,816 | -€5,057 | -1.8% |
| Amounts payable within one year | 42/48 | €204,089 | €203,799 | -€290 | -0.1% |
| Current portion of amounts payable after more than one year | 42 | €16,355 | €20,900 | +€4,545 | +27.8% |
| Trade debts | 44 | €89,120 | €97,411 | +€8,291 | +9.3% |
| Suppliers | 440/4 | €89,120 | €97,411 | +€8,291 | +9.3% |
| Taxes, remuneration and social security | 45 | €9,214 | €10,998 | +€1,783 | +19.4% |
| Remuneration and social security | 454/9 | €9,214 | €10,998 | +€1,783 | +19.4% |
| Other amounts payable | 47/48 | €89,400 | €74,491 | -€14,909 | -16.7% |
| Remuneration, social security and pensions | 62 | €54,171 | €64,242 | +€10,071 | +18.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €25,233 | €26,769 | +€1,536 | +6.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €1,918 | €6,287 | +€4,369 | +228% |
| Other operating charges | 640/8 | €2,235 | €2,260 | +€25 | +1.1% |
| Gross operating margin | 9900 | €194,265 | €161,544 | -€32,721 | -16.8% |
| Operating profit (loss) | 9901 | €110,708 | €61,985 | -€48,723 | -44.0% |
| Financial income | 75/76B | €4,236 | €2,255 | -€1,981 | -46.8% |
| Recurring financial income | 75 | €4,236 | €2,255 | -€1,981 | -46.8% |
| Financial charges | 65/66B | €19,579 | €20,255 | +€676 | +3.5% |
| Recurring financial charges | 65 | €19,579 | €20,255 | +€676 | +3.5% |
| Profit (loss) for the period before taxes | 9903 | €95,365 | €43,986 | -€51,379 | -53.9% |
| Income taxes | 67/77 | €15,960 | €4,838 | -€11,121 | -69.7% |
| Profit (loss) for the period | 9904 | €79,406 | €39,148 | -€40,258 | -50.7% |
| Profit (loss) for the period to be appropriated | 9905 | €79,406 | €39,148 | -€40,258 | -50.7% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.